NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00526643,CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients,https://clinicaltrials.gov/study/NCT00526643,CAPPA-2,TERMINATED,"The primary objective of this study is to evaluate the impact on overall survival (OS) of the addition of cisplatin to gemcitabine vs gemcitabine alone in patients with advanced NSCLC in poor clinical condition (PS 2), not previously treated.",NO,Non-Small Cell Lung Cancer,DRUG: gemcitabine|DRUG: cisplatin,"overall survival, one year","change in performance status, each cycle of chemotherapy|toxicity, each cycle of chemotherapy and every 3 months thereafter|quality of life, chemotherapy cycles 1 and 2|objective response, at 6 weeks and 12 weeks|progression free survival, one year",,"National Cancer Institute, Naples",Clinical Trials Promoting Group (APRIC/CTPG)|Gruppo Oncologico del Lazio (GOL)|Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente|Gruppo Oncologico Italiano di Ricerca Clinica(GOIRC)|Gruppo Oncologico Italia Meridionale|Northwest Oncology Cooperative Group(GONO),ALL,"ADULT, OLDER_ADULT",PHASE3,57,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CAPPA-2|2005-005631-97,2007-11,2012-12,2012-12,2007-09-10,,2017-03-28,"Azienda Ospedaliera S. Giuseppe Moscati, U.O. di Oncologia Medica, Monteforte Irpino, AV, 83024, Italy|Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica, Acquaviva delle Fonti, BA, 70021, Italy|Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale, Bari, BA, 70126, Italy|Istituto Scientifico S. Raffaele, Milano, MI, 20132, Italy|Azienda Ospedaliera C. Poma, Mantova, MN, 46100, Italy|Istituto Oncologico Veneto, Padova, PD, Italy|Ospedale E. Morelli, Sondalo, SO, 23039, Italy|Ospedale Senatore Antonio Perrino, Brindisi, Italy|A.O. Ospedale Mater Domini, Oncoematologia Università Magna Grecia, Catanzaro, Italy|Ospedale F. Veneziale, Isernia, Italy|A.O. Vito Fazzi, Lecce, Italy|Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B, Napoli, 80131, Italy|Ospedale Regional, Unità Operative di Oncologia, Parma, Italy|Ospedale San Camillo - Forlanini, Rome, Italy|Ospedale S. Felice a Cancello, San Felice a Cancello, Italy",
